China’s Moore Threads nears profitability amid soaring revenue in growing challenge to Nvidia’s dominance
Chinese AI chipmaker Moore Threads (688795.SH), reported a sharp surge in revenue and its first quarterly profit, positioning itself…
How Chinese autonomous driving giant Horizon Robotics is funding its own embodied AI competitors
By Da Cheung China’s tech sector is witnessing a massive influx of capital into embodied AI…
Testing DeepSeek V4: Outcoding Google as Beijing builds a shield against Nvidia
By Brent Li More than a year after the launch of its groundbreaking R1 model that…
The Tsinghua prodigy who turned ‘four-faced monsters’ into a $40 million AI business
By Li Yuan When generative AI rewrote text, images and video in rapid succession, 3D content…
Chinese tech firms push AI agent capabilities as the industry waits for DeepSeek V4
By Da Cheung A flurry of major artificial intelligence updates hit the market this week. Both…
China’s robot-joint makers are racing against time as mass production looms
By Yuan Jingming On a production line in Zhangjiang’s “Robot Valley”, a new kind of industrial…
ByteDance brushes off its vanishing profits
Time and destiny — ByteDance is in a race against both. The Chinese tech group, which…
Chinese streaming giant’s push for AI actors sparks backlash
By Da Cheung China’s iQiyi faces a backlash over its AI “actor library”, raising concerns about…
Honor’s robot smashes men’s half-marathon world record
By Da Cheung A humanoid robot called Lightning developed by smartphone maker Honor ran a half-marathon…
Luminous Ventures closes $700 million fund to back China’s next wave of AI and hard tech
China’s venture capital market has had its first blockbuster fundraising of 2026, underscoring renewed global appetite…
Latest
- Han’s CNC rides AI infrastructure boom, but expansion brings new risks
- China demonstrates novel net-catch rocket recovery system as it races to close the gap with SpaceX
- China turns to molten salt to tackle renewable energy storage bottlenecks in the national grid
- Dramatic slowdown in China’s range-extended electric vehicle market raises concerns over Xiaomi’s strategy
- Biokin’s new cancer drug secures historic approval in China, but Western regulatory hurdles loom
